Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Philippe Mercier

Neurological Surgery Saint Louis, MO Medical Doctor

NPI 1053710160 CMS profile 1337395

1201 S Grand Blvd Dept Of, Saint Louis, MO 63104

Open in the dashboard

General payments

$18,021

96 records reported · program years 2019–2025

Research payments

$216

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$99,649 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Philippe Mercier of Saint Louis, MO is reported in the CMS Open Payments database as having received $18,021 across 96 general payments and $216 in research payments paid to them. Separately, studies naming them as principal investigator received $99,649 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 77th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $562 13
2024 General $11,389 19
2023 General $2,396 9
2022 General $1,348 18
2021 General $243 9
2020 General $648 7
2019 General $1,436 21
2019 Research $216 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Philippe Mercier
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Philippe Mercier were reported at $562. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Philippe Mercier Neurological Surgery median Middle half National median
2019 $1,436 $582 $138–$3,006 $163
2020 $648 $294 $76–$2,174 $114
2021 $243 $387 $105–$2,432 $132
2022 $1,348 $542 $139–$2,989 $149
2023 $2,396 $534 $145–$2,697 $160
2024 $11,389 $574 $155–$3,046 $164
2025 $562 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. GT Medical Technologies, Inc $11,657 16 payments
  2. NeuroPace, Inc. $1,864 4 payments
  3. Medtronic, Inc. $1,611 35 payments
  4. Medtronic USA, Inc. $738 17 payments
  5. Zimmer Biomet Holdings, Inc. $616 8 payments
  6. Globus Medical, Inc. $587 2 payments
  7. Zavation LLC $335 2 payments
  8. CoreLink, LLC $280 6 payments
  9. Abbott Laboratories $221 4 payments
  10. SK Life Science, Inc. $98 1 payment
  11. Other $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $7,587 19 payments
  2. Consulting Fee $6,250 1 payment
  3. Food and Beverage $3,864 75 payments
  4. Entertainment $320 1 payment
Products named General payments · program years 2019–2025
  1. GammaTile Kxk $11,351 14 payments
  2. RNS Neurostimulator Kit $1,864 4 payments
  3. CD HORIZON SPINAL SYSTEM $823 10 payments
  4. Excelsius - GPS $587 2 payments
  5. ROSA $580 7 payments
  6. VISUALASE $577 6 payments
  7. GammaTile Cns $307 2 payments
  8. UNID_PASS $226 5 payments
  9. MAZOR X SYSTEM $202 7 payments
  10. Proclaim Family of SCS IPGs $179 2 payments
  11. Other $657 31 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Innovative Surgical Designs, Inc. $216 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

13

Median for Neurosurgery: 83

Drug cost

$181

Median for Neurosurgery: $872

Branded share of claims

100%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 13 $181

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 44 billing codes

Paid by Medicare

$34,850

Medicare's payments for the services billed

Medicare patients

61

Average age 65

Services billed

123

32 women, 29 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 74%
Arthritis 67%
Depression 36%
Diabetes 31%
Ischemic heart disease 26%
Chronic kidney disease 21%
Cancer 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

97 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record